Hypoxia increases adipogenesis and affects adipocytokine production in orbital fibroblasts - A possible explanation of the link between smoking and Graves' ophthalmopathy

International Journal of Ophthalmology

Volumn 7, Issue 3, 2014, Pages 403-407

  Chng, Chiaw Ling ^a   Lai, Oi Fah ^b   Chew, Charmaine Sze Min ^b   Peh, Yu Pei ^b   Fook Chong, Stephanie Man Chung ^b   Seah, Lay Leng ^c   Khoo, Daphne Hsu Chin ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b Sing Health Translational Immunology and Inflammation Centre   (Singapore)

^c SINGAPORE NATIONAL EYE CENTRE   (Singapore)

Author keywords

Graves' ophthalmopathy; Hypoxia; Smoking

Indexed keywords

EID: 84903830676     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2014.03.03     Document Type: Article

References (29)

1. Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves' ophthalmopathy. Thyroid. 2002; 12(10): 855-860. [PubMed]
2. Stan MN, Bahn RS Risk factors for development or deterioration of Graves' ophthalmopathy. Thyroid. 2010; 20(7): 777-783. [PMC free article] [PubMed]
3. Thornton J, Kelly SP, Harrison R.A., Edwards R. Cigarette smoking and thyroid eye disease: a systematic review. Eye (Lond) 2007; 21(9): 1135-1145. [PubMed]
4. Wiersinga WM. Smoking and thyroid. Clin Endocrinol (Oxf) 2013; 79(2): 145-151. [PubMed]
5. Bahn RS. Graves' ophthalmopathy. N Engl J Med. 2010; 362(8): 726-738. [PMC free article] [PubMed]
6. van Steensel L., Dik WA The orbital fibroblast: a key player and target for therapy in Graves' ophthalmopathy. Orbit. 2010; 29(4): 202-206. [PubMed]
7. Metcalfe RA, Weetman AP Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: possible role in thyroid-associated ophthalmopathy. Clin Endocrinol (Oxf) 1994; 40(1): 67-72. [PubMed]
8. Li B, Smith TJ Divergent expression of IL-1 receptor antagonists in CD34(+) fibrocytes and orbital fibroblasts in thyroid-associated ophthalmopathy: contribution of fibrocytes to orbital inflammation. J Clin Endocrinol Metab. 2013; 98(7): 2783-2790. [PMC free article] [PubMed]
9. Bartley GB, Gorman CA Diagnostic criteria for Graves' ophthalmopathy. Am J Ophthalmol. 1995; 119(6): 792-795. [PubMed]
10. Valyasevi RW, Erickson DZ, Harteneck D.A., Dutton CM, Heufelder AE, Jyonouchi SC, Bahn RS Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab. 1999; 84(7): 2557-2562. [PubMed]
11. Semenza GL. Hypoxia and human disease-and the Journal of Molecular Medicine. J Mol Med (Berl) 2007; 85(12): 1293-1294. [PubMed]
12. Hemmrich K, von Heimburg D, Cierpka K, Haydarlioglu S., Pallua N. Optimization of the differentiation of human preadipocytes in vitro. Differentiation. 2005; 73(1): 28-35. [PubMed]
13. Cawood TJ, Moriarty P, O'Farrelly C, O'Shea D. Smoking and thyroid-associated ophthalmopathy: a novel explanation of the biological link. J Clin Endocrinol Metab. 2007; 92(1): 59-64. [PubMed]
14. Tsai CC, Wu SB, Cheng C.Y., Kao SC, Kau HC, Chiou SH, Hsu W.M., Wei YH. Increased oxidative DNA damage, lipid peroxidation, and reactive oxygen species in cultured orbital fibroblasts from patients with Graves' ophthalmopathy: evidence that oxidative stress has a role in this disorder. Eye(Lond) 2010; 24(9): 1520-1525. [PubMed]
15. Duntas LH. The evolving role of selenium in the treatment of graves' disease and ophthalmopathy. J Thyroid Res. 2012; 2012: 736161. [PMC free article] [PubMed]
16. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol (1985) 2000; 88(4): 1474-1480. [PubMed]
17. Wang GL, Jiang BH, Rue E.A., Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 1995; 92(12): 5510-5514. [PMC free article] [PubMed]
18. Wang GL, Semenza GL Purification and characterization of hypoxia-inducible factor 1. J Biol Chem. 1995; 270(3): 1230-1237. [PubMed]
19. Erickson DZ, Harteneck DA, Erickson B.J., Dutton CM, Bahn RS. Induction of leptin expression in orbital preadipocyte fibroblasts. Thyroid. 2001; 11(3): 221-226. [PubMed]
20. Mitchell SE, Rees WD, Hardie L.J., Hoggard N., Tadayyon M, Arch JR, Trayhurn P. ob gene expression and secretion of leptin following differentiation of rat preadipocytes to adipocytes in primary culture. Biochem Biophys Res Commun. 1997; 230(2): 360-364. [PubMed]
21. Santos-Alvarez J., Goberna R, Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol. 1999; 194(1): 6-11. [PubMed]
22. Grunfeld C, Zhao C, Fuller J., Pollack A, Moser A, Friedman J., Feingold KR. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest. 1996; 97(9): 2152-2157. [PMC free article] [PubMed]
23. Kiguchi N, Maeda T, Kobayashi Y., Fukazawa Y, Kishioka S. Leptin enhances CC-chemokine ligand expression in cultured murine macrophage. Biochem Biophys Res Commun. 2009; 384(3): 311-315. [PubMed]
24. Zarkesh-Esfahani H., Pockley AG, Wu Z, Hellewell P.G., Weetman AP, Ross RJ. Leptin indirectly activates human neutrophils via induction of TNF-alpha. J Immunol. 2004; 172(3): 1809-1814. [PubMed]
25. Sierra-Honigmann M.R., Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A., Sessa WC, Madge LA, Schechner JS, Schwabb M.B., Polverini PJ, Flores-Riveros JR. Biological action of leptin as an angiogenic factor. Science. 1998; 281(5383): 1683-1686. [PubMed]
26. Chen MH, Chen MH, Liao S.L., Chang TC, Chuang LM. Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy. Clin Endocrinol (Oxf) 2008; 69(2): 332-337. [PubMed]
27. Gustafson B, Hammarstedt A, Andersson C.X., Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2007; 27(11): 2276-2283. [PubMed]
28. Famulla S, Horrighs A, Cramer A., Sell H, Eckel J. Hypoxia reduces the response of human adipocytes towards TNFalpha resulting in reduced NF-kappaB signaling and MCP-1 secretion. Int J Obes (Lond) 2012; 36(7): 986-992. [PubMed]
29. Prabhakar BS, Bahn RS, Smith TJ Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev. 2003; 24(6): 802-835. [PubMed]